Patricia J. LiWang

Affiliations: 
Purdue University, West Lafayette, IN, United States 
Area:
Biochemistry
Google:
"Patricia LiWang"
Mean distance: 39813
 

Children

Sign in to add trainee
Aaron A Hoskins research assistant 1997-1999 Purdue (DevTree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Stark LE, Guan W, Colvin ME, et al. (2021) The binding and specificity of chemokine binding proteins, through the lens of experiment and computation. Biomedical Journal
Stark LE, LiWang P, Colvin ME. (2020) Determining Factors that Influence vCCI Loop Interactions in vCCI-Chemokine Binding through MD Simulation Biophysical Journal. 118
Fischer K, Nguyen K, LiWang PJ. (2019) Griffithsin retains anti-HIV-1 potency with changes in gp120 glycosylation and complements broadly neutralizing antibodies PGT121 and PGT126. Antimicrobial Agents and Chemotherapy
Yavuz B, Morgan JL, Herrera C, et al. (2019) Sustained release silk fibroin discs: Antibody and protein delivery for HIV prevention. Journal of Controlled Release : Official Journal of the Controlled Release Society. 301: 1-12
Stark LE, LiWang PJ, Colvin ME. (2018) Evaluating Protein - Protein Interactions in Chemokine - Inhibitor Complexes using MD Simulation Biophysical Journal. 114
Nguyen AF, Kuo NW, Showalter LJ, et al. (2017) Biophysical and Computational Studies of the vCCI:vMIP-II Complex. International Journal of Molecular Sciences. 18
Zhang L, Herrera C, Coburn J, et al. (2017) Stabilization and Sustained Release of HIV Inhibitors by Encapsulation in Silk Fibroin Disks Acs Biomaterials Science & Engineering. 3: 1654-1665
Zhang L, LiWang PJ. (2014) Chemokine-receptor interactions: solving the puzzle, piece by piece. Structure (London, England : 1993). 22: 1550-2
Kuo NW, Gao YG, Schill MS, et al. (2014) Structural insights into the interaction between a potent anti-inflammatory protein, viral CC chemokine inhibitor (vCCI), and the human CC chemokine, Eotaxin-1. The Journal of Biological Chemistry. 289: 6592-603
Xue J, Hoorelbeke B, Kagiampakis I, et al. (2013) The griffithsin dimer is required for high-potency inhibition of HIV-1: evidence for manipulation of the structure of gp120 as part of the griffithsin dimer mechanism. Antimicrobial Agents and Chemotherapy. 57: 3976-89
See more...